This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event
In-Person: October 11-13 • Virtual: October 18-20Hyatt Regency • New Brunswick, NJ

Erin Bell
Senior Commercial Counsel at Zealand Pharma


Erin is currently at Zealand Pharma US, Inc. where she supports the needs of the US Commercial organization in all aspects of its first launched product, Zegalogue. Before Zealand, Erin was at Pear Therapeutics, Inc., a digital health company, where she served as Assistant General Counsel. At Pear, Erin participated in the launch of Somryst, the company’s third FDA-approved product and helped build Pear’s Compliance Program. Prior to joining Pear, Erin was Senior Counsel at Sunovion Pharmaceuticals, Inc. and acted as legal brand lead for Latuda, a drug that ultimately achieved blockbuster status. At Sunovion, Erin was also part of the litigation team that secured four additional years of patent exclusivity in the market for Latuda. Prior to Sunovion, Erin worked at PerkinElmer, a medical device company, where she provided counsel to several of the company’s subsidiaries. Erin earned her BS from Clark University and her JD from Suffolk University School of Law.

Agenda Sessions

  • Panel: Developing and Utilizing a Contract Pricing or GP Steering Committee or Working Group